Clinical trial
Glucagon-like Peptide-1 Receptor Agonist for Reduction of Myocardial Injury After Non-Cardiac Surgery
NCT06324461 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucagon-like Peptide-1 Receptor Agonist for Reduction of Myocardial Injury After Non-Cardiac Surgery
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 20, 2024
- Completion date
- December 31, 2028
- Enrollment
- 372 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial injury